Early Management of Retained Hemothorax in Blunt Head and Chest Trauma
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Measuring Injury Severity
Measuring Injury Severity A brief introduction Thomas Songer, PhD University of Pittsburgh [email protected] Injury severity is an integral component in injury research and injury control. This lecture introduces the concept of injury severity and its use and importance in injury epidemiology. Upon completing the lecture, the reader should be able to: 1. Describe the importance of measuring injury severity for injury control 2. Describe the various measures of injury severity This lecture combines the work of several injury professionals. Much of the material arises from a seminar given by Ellen MacKenzie at the University of Pittsburgh, as well as reference works, such as that by O’Keefe. Further details are available at: “Measuring Injury Severity” by Ellen MacKenzie. Online at: http://www.circl.pitt.edu/home/Multimedia/Seminar2000/Mackenzie/Mackenzie.ht m O’Keefe G, Jurkovich GJ. Measurement of Injury Severity and Co-Morbidity. In Injury Control. Rivara FP, Cummings P, Koepsell TD, Grossman DC, Maier RV (eds). Cambridge University Press, 2001. 1 Degrees of Injury Severity Injury Deaths Hospitalization Emergency Dept. Physician Visit Households Material in the lectures before have spoken of the injury pyramid. It illustrates that injuries of differing levels of severity occur at different numerical frequencies. The most severe injuries occur less frequently. This point raises the issue of how do you compare injury circumstances in populations, particularly when levels of severity may differ between the populations. 2 Police EMS Self-Treat Emergency Dept. doctor Injury Hospital Morgue Trauma Center Rehab Center Robertson, 1992 For this issue, consider that injuries are often identified from several different sources. -
Intracranial Hemorrhage As Initial Presentation of Cerebral Venous Sinus Thrombosis
Case Report Journal of Heart and Stroke Published: 31 Dec, 2019 Intracranial Hemorrhage as Initial Presentation of Cerebral Venous Sinus Thrombosis Joseph Y Chu1* and Marc Ossip2 1Department of Medicine, University of Toronto, Canada 2Department of Diagnostic Imaging, William Osler Health System, Canada Abstract Intracranial Hemorrhage (ICH) as initial presentation is an uncommon complication of Cerebral Venous-Sinus Thrombosis (CVT). Clinical and neuro-imaging studies of 4 cases of ICH due cerebral venous-sinus thrombosis seen at the William Osler Health System in Toronto will be presented. Discussion of the immediate and long-term management of these interesting cases will be reviewed with emphasis on the appropriate neuro-imaging studies. Literature review of Direct Oral Anticoagulants (DOAC) in the long-term management of these challenging cases will be discussed. Introduction The following are four cases of Cerebral Venous-Sinus Thrombosis (CVT) who present initially as Intracranial Hemorrhage (ICH). Clinical details, including immediate and long term management and neuro-imaging studies are presented. Results Case 1 A 43 years old R-handed house wife, South-Asian decent, who was admitted to hospital on 06- 10-2014 with sudden headache and right hemiparesis. Her past health shows no prior hypertension or stroke. She is not on any hormone replacement therapy, non-smoker and non-drinker. Married with 1 daughter. Examination shows BP=122/80, P=70 regular, GCS=15, with right homonymous hemianopsia, right hemiparesis: arm=leg 1/5, extensor R. Plantar response. She was started on IV Heparin after her unenhanced CT showed acute left parietal intracerebral hemorrhage and her MRV showed extensive sagittal sinus thrombosis extending into the left transverse OPEN ACCESS sinus (Figures 1,2). -
Assessing the Severity of Traumatic Brain Injury—Time for a Change?
Journal of Clinical Medicine Review Assessing the Severity of Traumatic Brain Injury—Time for a Change? Olli Tenovuo 1,2,*, Ramon Diaz-Arrastia 3, Lee E. Goldstein 4, David J. Sharp 5,6, Joukje van der Naalt 7 and Nathan D. Zasler 8,9 1 Division of Clinical Neurosciences, Turku Brain Injury Centre, Turku University Hospital, 20521 Turku, Finland 2 Department of Neurology, Institute of Clinical Medicine, University of Turku, 20500 Turku, Finland 3 Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; [email protected] 4 Alzheimer’s Disease Research Center, College of Engineering, Boston University School of Medicine, Boston, MA 02118, USA; [email protected] 5 Clinical, cognitive and computational neuroimaging laboratory (C3NL), Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, W12 0NN, UK; [email protected] 6 UK Dementia Research Institute Care Research and Technology Centre, Imperial College London and the University of Surrey, London, W12 0NN UK 7 Department of Neurology, University of Groningen, University Medical Center Groningen, 9713 GZ Groning-en, The Netherlands; [email protected] 8 Concussion Care Centre of Virginia and Tree of Life, Richmond, VA 23233, USA; [email protected] 9 Department of Physical Medicine and Rehabilitation, Virginia Commonwealth University, Richmond, VA 23284, USA * Correspondence: olli.tenovuo@tyks.fi; Tel.: +358-50-438-3802 Abstract: Traumatic brain injury (TBI) has been described to be man’s most complex disease, in man’s most complex organ. Despite this vast complexity, variability, and individuality, we still classify the severity of TBI based on non-specific, often unreliable, and pathophysiologically poorly understood measures. -
Symptomatic Intracranial Hemorrhage (Sich) and Activase® (Alteplase) Treatment: Data from Pivotal Clinical Trials and Real-World Analyses
Symptomatic intracranial hemorrhage (sICH) and Activase® (alteplase) treatment: Data from pivotal clinical trials and real-world analyses Indication Activase (alteplase) is indicated for the treatment of acute ischemic stroke. Exclude intracranial hemorrhage as the primary cause of stroke signs and symptoms prior to initiation of treatment. Initiate treatment as soon as possible but within 3 hours after symptom onset. Important Safety Information Contraindications Do not administer Activase to treat acute ischemic stroke in the following situations in which the risk of bleeding is greater than the potential benefit: current intracranial hemorrhage (ICH); subarachnoid hemorrhage; active internal bleeding; recent (within 3 months) intracranial or intraspinal surgery or serious head trauma; presence of intracranial conditions that may increase the risk of bleeding (e.g., some neoplasms, arteriovenous malformations, or aneurysms); bleeding diathesis; and current severe uncontrolled hypertension. Please see select Important Safety Information throughout and the attached full Prescribing Information. Data from parts 1 and 2 of the pivotal NINDS trial NINDS was a 2-part randomized trial of Activase® (alteplase) vs placebo for the treatment of acute ischemic stroke. Part 1 (n=291) assessed changes in neurological deficits 24 hours after the onset of stroke. Part 2 (n=333) assessed if treatment with Activase resulted in clinical benefit at 3 months, defined as minimal or no disability using 4 stroke assessments.1 In part 1, median baseline NIHSS score was 14 (min: 1; max: 37) for Activase- and 14 (min: 1; max: 32) for placebo-treated patients. In part 2, median baseline NIHSS score was 14 (min: 2; max: 37) for Activase- and 15 (min: 2; max: 33) for placebo-treated patients. -
NIH Public Access Author Manuscript J Neuropathol Exp Neurol
NIH Public Access Author Manuscript J Neuropathol Exp Neurol. Author manuscript; available in PMC 2010 September 24. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: J Neuropathol Exp Neurol. 2009 July ; 68(7): 709±735. doi:10.1097/NEN.0b013e3181a9d503. Chronic Traumatic Encephalopathy in Athletes: Progressive Tauopathy following Repetitive Head Injury Ann C. McKee, MD1,2,3,4, Robert C. Cantu, MD3,5,6,7, Christopher J. Nowinski, AB3,5, E. Tessa Hedley-Whyte, MD8, Brandon E. Gavett, PhD1, Andrew E. Budson, MD1,4, Veronica E. Santini, MD1, Hyo-Soon Lee, MD1, Caroline A. Kubilus1,3, and Robert A. Stern, PhD1,3 1 Department of Neurology, Boston University School of Medicine, Boston, Massachusetts 2 Department of Pathology, Boston University School of Medicine, Boston, Massachusetts 3 Center for the Study of Traumatic Encephalopathy, Boston University School of Medicine, Boston, Massachusetts 4 Geriatric Research Education Clinical Center, Bedford Veterans Administration Medical Center, Bedford, Massachusetts 5 Sports Legacy Institute, Waltham, MA 6 Department of Neurosurgery, Boston University School of Medicine, Boston, Massachusetts 7 Department of Neurosurgery, Emerson Hospital, Concord, MA 8 CS Kubik Laboratory for Neuropathology, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts Abstract Since the 1920s, it has been known that the repetitive brain trauma associated with boxing may produce a progressive neurological deterioration, originally termed “dementia pugilistica” and more recently, chronic traumatic encephalopathy (CTE). We review the 47 cases of neuropathologically verified CTE recorded in the literature and document the detailed findings of CTE in 3 professional athletes: one football player and 2 boxers. -
Canadian Stroke Best Practice Recommendations
CANADIAN STROKE BEST PRACTICE RECOMMENDATIONS MANAGEMENT OF SPONTANEOUS INTRACEREBRAL HEMORRHAGE Seventh Edition - New Module 2020 Ashkan Shoamanesh (Co-chair), M. Patrice Lindsay, Lana A Castellucci, Anne Cayley, Mark Crowther, Kerstin de Wit, Shane W English, Sharon Hoosein, Thien Huynh, Michael Kelly, Cian J O’Kelly, Jeanne Teitelbaum, Samuel Yip, Dar Dowlatshahi, Eric E Smith, Norine Foley, Aleksandra Pikula, Anita Mountain, Gord Gubitz and Laura C. Gioia(Co-chair), on behalf of the Canadian Stroke Best Practices Advisory Committee in collaboration with the Canadian Stroke Consortium and the Canadian Hemorrhagic Stroke Trials Initiative Network (CoHESIVE). © 2020 Heart & Stroke October 2020 Heart and Stroke Foundation Management of Spontaneous Intracerebral Hemorrhage Canadian Stroke Best Practice Recommendations Table of Contents CANADIAN STROKE BEST PRACTICE RECOMMENDATIONS MANAGEMENT OF SPONTANEOUS INTRACERBRAL HEMORRHAGE SEVENTH EDITION, 2020 Table of Contents Topic Page Part One: Canadian Stroke Best Practice Recommendations Introduction and Overview I. Introduction 3 II. Spontaneous Intracerebral Hemorrhage Module Overview 3 III. Spontaneous Intracerebral Hemorrhage Definitions 4 IV. Guideline Development Methodology 4 V. Acknowledgements, Funding, Citation 6 VI. Figure One: Intracerebral Hemorrhage Patient Flow Map 8 Part Two: Canadian Stroke Best Practice Recommendations Spontaneous Intracerebral Hemorrhage 1. Emergency Management of Intracerebral Hemorrhage 9 1.1 Initial Clinical Assessment of Intracerebral Hemorrhage 9 1.2 Blood Pressure Management 10 1.3 Management of Anticoagulation 11 1.4 Consultation with Neurosurgery 12 1.5 Neuroimaging 12 1.5.1 Recommended additional urgent neuroimaging to confirm ICH diagnosis 12 1.5.2 Recommended additional etiological neuroimaging 13 1.6 Surgical management of Intracerebral Hemorrhage 13 Box One: Symptoms of Intracerebral Hemorrhage: 15 Box Two: Modified Boston Criteria (Linn 2010) 16 2. -
201 a Abbreviated Injury Severity Score (AIS) , 157 Abdominal Injuries , 115 Acetylsalicylic Acid (ASA) , 14 Acromioclavicular (
Index A incentive spirometry , 151 Abbreviated Injury Severity Score (AIS) , 157 indications , 143–144 Abdominal injuries , 115 insertion technique , 144–145 Acetylsalicylic acid (ASA) , 14 mechanical ventilation , 152 Acromioclavicular (AC) joint , 166, 177 mechanics , 143 Acute respiratory distress syndrome (ARDS) , 28, 157 operative fi xation, of rib fractures , 145 Advanced Trauma Life Support (ATLS) , 3, 101 pneumonia , 151–152 Airway pressure release ventilation (APRV) , 48 Chest X ray , 42, 43 Allman classifi cation , 166 Clavicle fractures , 5 Analgesia , 109, 196 acromioclavicular joint dislocations , 166 comprehensive approach , 148 Allman classifi cation , 166 direct operative exposure , 148 clinical evaluation , 166–167 elderly patients , 149, 151 development , 164 epidural analgesia , 149 distal clavicle fractures , 172–175 intercostal nerve blocks , 149 epidemiology , 164 opioids , 148–149 history , 163 Antibiotic prophylaxis , 145 intramedullary nail fi xation , 172 Antibiotics , 48, 113, 134, 145, 152 muscle groups/deforming forces , 165 Arterial blood gases , 42 nonoperative treatment , 167–168 operative dangers , 165–166 operative treatment , 169–170 B osteology , 164 Bioabsorbable implants , 67–70 plate fi xation , 170–172 Bioabsorbable plates , 127 Computed tomography , 106 Blunt cardiac injury , 107–108 CONsolidated Standards Of Reporting Trials Blunt cerebrovascular injury , 106 (CONSORT) Statement , 192 Blunt thoracic aortic injury , 106–107 Continuous positive airway pressure (CPAP) , 35, 152 Bronchoalveolar lavage -
Original Article Clinical Effectiveness Analysis of Dextran 40 Plus Dexamethasone on the Prevention of Fat Embolism Syndrome
Int J Clin Exp Med 2014;7(8):2343-2346 www.ijcem.com /ISSN:1940-5901/IJCEM0001158 Original Article Clinical effectiveness analysis of dextran 40 plus dexamethasone on the prevention of fat embolism syndrome Xi-Ming Liu1*, Jin-Cheng Huang2*, Guo-Dong Wang1, Sheng-Hui Lan1, Hua-Song Wang1, Chang-Wu Pan3, Ji-Ping Zhang2, Xian-Hua Cai1 1Department of Orthopaedics, Wuhan General Hospital of Guangzhou Command, Wuhan 430070, China; 2Depart- ment of Orthopaedics, The Second People’s Hospital of Yichang 443000, Hubei, China; 3Department of Orthopae- dics, The People’s Hospital of Tuanfeng 438000, Hubei, China. *Equal contributors. Received June 19, 2014; Accepted July 27, 2014; Epub August 15, 2014; Published August 30, 2014 Abstract: This study aims to investigate the clinical efficacy of Dextran 40 plus dexamethasone on the prevention of fat embolism syndrome (FES) in high-risk patients with long bone shaft fractures. According to the different preventive medication, a total of 1837 cases of long bone shaft fracture patients with injury severity score (ISS) > 16 were divided into four groups: dextran plus dexamethasone group, dextran group, dexamethasone group and control group. The morbidity and mortality of FES in each group were analyzed with pairwise comparison analysis. There were totally 17 cases of FES and 1 case died. The morbidity of FES was 0.33% in dextran plus dexamethasone group and significantly lowers than that of other groups (P < 0.05). There was no significant difference among other groups (P > 0.05). Conclusion from our data is dextran 40 plus dexamethasone can effectively prevent long bone shaft fractures occurring in high-risk patients with FES. -
Underestimated Traumatic Brain Injury in Multiple Injured Patients; Is the Glasgow Coma Scale a Reliable Tool?
Research Artice iMedPub Journals Trauma & Acute Care 2017 http://www.imedpub.com/ Vol.2 No.2:42 Underestimated Traumatic Brain Injury in Multiple Injured Patients; Is the Glasgow Coma Scale a Reliable Tool? Ladislav Mica1*, Kai Oliver Jensen1, Catharina Keller2, Stefan H. Wirth3, Hanspeter Simmen1 and Kai Sprengel1 1Division of Trauma Surgery, University Hospital of Zürich, 8091 Zürich, Switzerland 2LVR-Klinik, 51109 Köln, Germany 3Orthopädische Universitätsklink Balgrist, 8008 Zürich, Switzerland *Corresponding author: Ladislav Mica, Division of Trauma Surgery, University Hospital of Zürich, 8091 Zürich, Switzerland, Tel: +41 44 255 41 98; E- mail: [email protected] Received date: March 16, 2017; Accepted date: April 12, 2017; Published date: April 20, 2017 Citation: Mica L, Jensen KO, Keller C, Wirth SH, Simmen H, et al. (2017) Underestimated Traumatic Brain Injury in Multiple Injured Patients, is the Glasgow Coma Scale a Reliable Tool? Trauma Acute Care 2: 42. Copyright: © 2017 Mica L, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abbreviations: Abstract AIS: Abbreviated Injury Severity Score; ANOVA: Analysis of Variance; APACHE II: Acute Physiology and Chronic Health Background: Traumatic brain injuries are common in Evaluation; ATLS: Advanced Trauma Life Support; AUC: Area multiple injured patients. Here, the impact of traumatic under the Curve; CT: Computed Tomography; GCS: Glasgow brain injuries according age and mortality and predictive Coma Scale; IBM: International Business Machines Corporation; value was investigated. ISS: Injury Severity Score; NISS: New Injury Severity Score; ROC: Methods: Totally 2952 patients were included into this Receiver Operating Curve; SAPS: Simplified Acute Physiology sample. -
Injury Severity Scoring
INJURY SEVERITY SCORING Injury Severity Scoring is a process by which complex and variable patient data is reduced to a single number. This value is intended to accurately represent the patient's degree of critical illness. In truth, achieving this degree of accuracy is unrealistic and information is always lost in the process of such scoring. As a result, despite a myriad of scoring systems having been proposed, all such scores have both advantages and disadvantages. Part of the reason for such inaccuracy is the inherent anatomic and physiologic differences that exist between patients. As a result, in order to accurately estimate patient outcome, we need to be able to accurately quantify the patient's anatomic injury, physiologic injury, and any pre-existing medical problems which negatively impact on the patient's physiologic reserve and ability to respond to the stress of the injuries sustained. Outcome = Anatomic Injury + Physiologic Injury + Patient Reserve GLASGOW COMA SCORE The Glasgow Coma Score (GCS) is scored between 3 and 15, 3 being the worst, and 15 the best. It is composed of three parameters : Best Eye Response, Best Verbal Response, Best Motor Response, as given below: Best Eye Response (4) Best Verbal Response (5) Best Motor Response (6) 1. No eye opening 1. No verbal response 1. No motor response 2. Eye opening to pain 2. Incomprehensible sounds 2. Extension to pain 3. Eye opening to verbal 3. Inappropriate words 3. Flexion to pain command 4. Confused 4. Withdrawal from pain 4. Eyes open spontaneously 5. Orientated 5. Localising pain 6. Obeys Commands Note that the phrase 'GCS of 11' is essentially meaningless, and it is important to break the figure down into its components, such as E3 V3 M5 = GCS 11. -
Guidelines for BLS/ALS Medical Providers Current As of March 2019
Tactical Emergency Casualty Care (TECC) Guidelines for BLS/ALS Medical Providers Current as of March 2019 DIRECT THREAT CARE (DTC) / HOT ZONE Guidelines: 1. Mitigate any immediate threat and move to a safer position (e.g. initiate fire attack, coordinated ventilation, move to safe haven, evacuate from an impending structural collapse, etc). Recognize that threats are dynamic and may be ongoing, requiring continuous threat assessments. 2. Direct the injured first responder to stay engaged in the operation if able and appropriate. 3. Move patient to a safer position: a. Instruct the alert, capable patient to move to a safer position and apply self-aid. b. If the patient is responsive but is injured to the point that he/she cannot move, a rescue plan should be devised. c. If a patient is unresponsive, weigh the risks and benefits of an immediate rescue attempt in terms of manpower and likelihood of success. Remote medical assessment techniques should be considered to identify patients who are dead or have non-survivable wounds. 4. Stop life threatening external hemorrhage if present and reasonable depending on the immediate threat, severity of the bleeding and the evacuation distance to safety. Consider moving to safety prior to application of the tourniquet if the situation warrants. a. Apply direct pressure to wound, or direct capable patient to apply direct pressure to own wound and/or own effective tourniquet. b. Tourniquet application: i. Apply the tourniquet as high on the limb as possible, including over the clothing if present. ii. Tighten until cessation of bleeding and move to safety. -
Read Onlinepdf 18.98 MB
ResidentOfficial Publication of the Emergency Medicine Residents’ Association December 2018/January 2019 VOL 45 / ISSUE 6 Exertional Rhabdomyolysis EmBassador Travel Team Seeking the Best and Brightest EM Physicians Enjoy the flexibility to live where you want and practice where you are needed. EmBassador TRAVEL TEAM PHYSICIANS RECEIVE: Paid travel and Practice variety accommodations Concierge support Travel convenience package Regional engagements, Paid medical staff dues, equitable scheduling and licenses, certifications and no mandatory long-term applications employment commitment Exceptional Fast track to future compensation package leadership opportunities For More Information: Mansoor Khan, MD National Director, EmBassador Program 917.656.6958 | [email protected] ENVISION PHYSICIAN SERVICES OFFERS ... programs that align physicians to become leaders MANSOOR KHAN, MD, MHA, FAAEM EMERGENCY MEDICINE Why EM Residents choose Envision Physician Services ■ Professional Development and Career Advancement ■ Employment Flexibility: Full-Time, Part-Time, moonlighting and travel team. Employed and Independent Contractor options ■ Practice Variety: Coast-to-coast opportunities at well-recognized hospitals and health systems ■ Unparalleled practice support ■ Earn While You Learn Program: Provides senior residents with $2,500/month while you complete your residency For more information, contact: 877.226.6059 [email protected] TABLE OF CONTENTS EDITORIAL STAFF Categories EDITOR-IN-CHIEF Tommy Eales, DO Indiana University COVER STORY DEPUTY